US Educational Support Service for MS Community, MS LifeLines
Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
European Medicines Agency starts review of Pandemrix
Orphagen Pharmaceuticals Awarded Phase 2 SBIR Funding to Investigate Novel Drug Class for CNS Disorders
QRxPharma to Sponsor Symposium at International Association for the Study of Pain Meetings
Clients in focus...
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us